48. Primary antiphospholipid syndrome Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 5 / Drugs : 6 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathways : 7
Drugs and their primary sponsors and trial info
EPA and DHA supplementation
University of Sao Paulo
2014 - NCT01956188 Brazil;
Hydroxychloroquine
National and Kapodistrian University of Athens
2013 - NCT04153201 Greece;
University Hospital, Angers
2018 Phase 3 NCT03540810 France;
Telitacicept
Peking Union Medical College Hospital
2021 Phase 2 NCT05078710 China;
University of Sao Paulo
2014 - NCT01956188 Brazil;
Hydroxychloroquine
National and Kapodistrian University of Athens
2013 - NCT04153201 Greece;
University Hospital, Angers
2018 Phase 3 NCT03540810 France;
Telitacicept
Peking Union Medical College Hospital
2021 Phase 2 NCT05078710 China;